CER Writers: Clinical Evaluation Report Cost Guide 2026

Executive Summary

Several factors affect the overall cost of preparing a Clinical Evaluation Report (CER), including the type of medical device, the available clinical evidence, and the work needed to meet the clinical evaluation requirements of the EU Medical Device Regulation (MDR).

Whether a manufacturer requires a new CER or an update to an existing report can also affect the cost. An established CER supported by current clinical evidence and well-maintained documentation may require less work than preparing a clinical evaluation from the beginning.

This guide examines CER writing costs, how pricing is determined, the services that may be included in a quotation, and what manufacturers should consider when selecting a CER writer.

Key Takeaways

• CER writing costs are influenced by both writer-related factors (experience, pricing model, provider type) and device-related factors (classification, clinical evidence, existing documentation)
• Advertised freelance CER writer rates range from USD 30 to USD 110 per hour on specialist platforms; these are indicative rather than industry-standard rates
• Fixed-price CER packages from one regulatory consultancy range from USD 6,100 for Class I devices to USD 12,400 for Class III devices
• Higher-risk devices generally involve more extensive clinical evidence assessment and may require specialist expertise, increasing cost
• A quotation should clearly define which activities are included: literature searches, clinical data appraisal, CEP development, CER drafting, and quality review are not always bundled together
• Manufacturers should clarify scope, revision rounds, additional work arrangements, and notified body deficiency support before accepting a quotation
• Updating an existing CER is often but not always cheaper than preparing a new one, depending on the condition of existing documentation and evidence gaps

Table of Contents

1. Direct Answer: How Much Does a CER Writer Cost?
2. Why It Matters: Understanding CER Writing Costs Under EU MDR
3. How It Works: Pricing Models and What Is Included
4. Common Mistakes: What Manufacturers Get Wrong When Procuring CER Writing
5. Best Practices: How to Get an Accurate CER Writing Quote
6. Comparison Table
7. Checklist
8. Definitions
9. Expert Perspective
10. FAQ
11. References
12. Related Resources
13. Call to Action

Direct Answer: How Much Does a CER Writer Cost?

There is no fixed standard price for CER writing. Costs vary based on the writer’s experience, the pricing model used, the device classification, and the scope of work required.

As indicative reference points from publicly advertised pricing in September 2026:

Freelance hourly rates on one specialist platform range from USD 30 to USD 110 per hour.

Fixed-price packages from one regulatory consultancy range from USD 6,100 for Class I devices to USD 12,400 for Class III devices, covering the Clinical Evaluation Plan, Clinical Evaluation Report, systematic literature review, and clinical data analysis.

These figures represent specific providers’ published pricing for defined service packages and do not establish standard CER costs across the industry. The actual cost for any given project depends on the specific device, available evidence, and agreed scope of work.

Why It Matters: Understanding CER Writing Costs Under EU MDR

Under EU MDR 2017/745, clinical evaluation is a continuous lifecycle obligation. Article 61 and Annex XIV require manufacturers to systematically identify, appraise, and analyse clinical evidence supporting the device’s safety, performance, and benefit-risk profile, and to maintain this documentation throughout the device lifecycle.

A Clinical Evaluation Report is not a one-time document. It must be updated as new clinical evidence, post-market surveillance findings, and PMCF data become available. For manufacturers without in-house clinical evaluation expertise, this creates an ongoing requirement for external CER writing support.

Understanding what drives CER writing costs helps manufacturers plan their clinical evaluation budget realistically, compare quotations on a like-for-like basis, and select a provider whose expertise matches the complexity of their device and clinical evidence requirements.

How Device Classification Affects CER Cost

The depth and extent of clinical evaluation should be proportionate to the device’s nature, classification, intended purpose, and risks. Higher-risk devices may require more extensive clinical evidence assessment, which can increase the work involved in preparing a Clinical Evaluation Report.

Under Article 61 of the MDR, implantable and Class III devices are subject to specific clinical investigation requirements, with defined exceptions. Where these requirements apply, the CER writing project may involve assessing clinical investigation data or documenting the justification for relying on an applicable exception.

How It Works: Pricing Models and What Is Included

CER Writer Pricing Models: Hourly, Fixed-Price, and Retainer Agreements

CER writing services may be offered through hourly rates, fixed-price projects, or ongoing support agreements.

Hourly CER Writing Rates

Under an hourly pricing model, manufacturers pay for the time spent completing the agreed clinical evaluation activities. The total cost depends on the writer’s hourly rate and the number of hours required to complete the work. Hourly arrangements may be used for targeted literature reviews, clinical data appraisal, CER revisions, or support with specific notified body questions.

As an example of publicly advertised freelance pricing, CER writing rates range from USD 30 to USD 110 per hour on one specialist freelance platform. These advertised rates illustrate the variation in individual writers’ fees and should not be interpreted as an industry-wide average. Writers with specialised clinical and EU MDR regulatory expertise may charge higher rates depending on the device’s complexity and the extent of clinical evidence assessment required.

Manufacturers considering hourly CER writing services should agree on the expected scope, estimated hours, deliverables, and arrangements for approving additional work.

Fixed-Price CER Writing Projects

A fixed-price arrangement establishes an agreed fee for a defined scope of work. This model may be used for preparing a new CER, updating an existing report, or completing a clinical evaluation package that includes supporting activities such as literature searches and clinical data appraisal.

The quotation should identify the services and deliverables included in the agreed fee. A fixed-price project may cover CER drafting and quality review, while literature searches, CEP development, or additional regulatory support are priced separately.

As an example of publicly advertised fixed-price services, one regulatory consultancy lists the following introductory prices for EU MDR CEP and CER packages:

The advertised packages include the Clinical Evaluation Plan, Clinical Evaluation Report, systematic literature review, and clinical data analysis. These figures represent one provider’s pricing for a defined service package and do not establish standard CER costs for each device classification.

Retainer and Ongoing CER Support

Manufacturers requiring clinical evaluation support across multiple devices or throughout the device lifecycle may benefit from a retainer or ongoing service agreement. The scope may include clinical literature surveillance, review of new PMS and PMCF findings, CER maintenance, and support with related clinical evaluation documentation.

Retainer arrangements may be structured around an agreed number of hours, defined services, or a recurring fee. The manufacturer and service provider should establish which activities are included, how additional work is billed, and whether periodic CER updates are covered by the agreement.

What Is Included in CER Writing Costs?

CER writing costs reflect the work involved in assessing and documenting the clinical evidence supporting a device’s safety, performance, and clinical benefits. The following activities may be included in a CER writing project:

Clinical Evaluation Plan (CEP): Developing or reviewing the CEP to establish the clinical evaluation strategy, including the device’s intended purpose, clinical claims, evidence requirements, and evaluation methods.

Literature search and screening: Developing search strategies, identifying and screening relevant publications, and documenting the search methodology and selection process.

Clinical data appraisal and analysis: Assessing the quality, relevance, and applicability of available clinical data and analysing whether the evidence supports the device’s safety, performance, and clinical benefits.

State-of-the-art assessment: Reviewing current clinical practice, relevant treatment or diagnostic alternatives, clinical guidelines, and accepted safety and performance benchmarks.

PMS and PMCF evidence review: Reviewing relevant post-market findings to identify emerging risks, performance trends, and clinical evidence gaps that may affect the evaluation.

Benefit-risk assessment: Evaluating the available clinical evidence in relation to the device’s identified risks and expected clinical benefits, with reference to the manufacturer’s risk management documentation.

CER drafting and documentation: Integrating the clinical evidence, appraisal and analysis results, state-of-the-art assessment, and clinical evaluation conclusions into a structured report.

Quality review and revisions: Reviewing the CER for accuracy, completeness, and consistency with the relevant clinical evaluation documentation, followed by revisions within the agreed project scope.

Manufacturers should confirm which activities and deliverables are included in a quotation before comparing CER writing costs. A quote covering CER drafting alone may differ substantially from one that includes literature searches, clinical data appraisal, supporting documentation, and quality review.

Common Mistakes: What Manufacturers Get Wrong When Procuring CER Writing

Comparing quotations that cover different scopes

A CER writing quotation that covers drafting alone is not comparable to one that includes literature searches, clinical data appraisal, CEP development, and quality review. Manufacturers who select the lowest-cost quotation without confirming what is included frequently discover that additional activities are billed separately, making the final cost significantly higher than anticipated.

Assuming an update is always cheaper than a new CER

While updating an existing CER is often less expensive than preparing one from the beginning, this depends on the condition of existing documentation. A CER with significant evidence gaps, outdated literature reviews, or inconsistencies with current PMS and PMCF findings may require substantial rework that approaches the cost of a new evaluation.

Not clarifying revision and additional work arrangements

Fixed-price quotations typically include a defined number of revision rounds. Where manufacturer feedback, new evidence, or notified body findings require additional revisions, these are usually billed separately. Manufacturers who do not clarify these arrangements upfront can face unexpected costs when the project scope expands.

Selecting a writer without relevant device expertise

CER writing requires clinical and regulatory expertise relevant to the specific device technology, intended purpose, and clinical evidence requirements. A writer with strong general MDR knowledge may not have the device-specific clinical expertise needed to critically appraise evidence for a novel implantable or a high-risk diagnostic device. The consequence is often a CER that appears complete but fails to withstand Notified Body scrutiny. For a full breakdown of the most common reasons CERs are challenged during regulatory review see our article on reasons Clinical Evaluation Reports are rejected.

Not providing complete documentation at the outset

Where manufacturers provide incomplete device information, existing clinical evidence, or post-market documentation when requesting a quotation, the agreed scope and cost may not reflect the full extent of work required. A preliminary documentation review before project start can help identify gaps and produce a more accurate quotation.

Best Practices: How to Get an Accurate CER Writing Quote

Questions manufacturers should consider before selecting a provider

Am I preparing a new CER or updating an existing report? An established CER with current clinical evidence may require targeted support, while a new CER or one with significant evidence gaps may involve a broader scope of work.

What level of clinical and regulatory expertise is required? The provider should have experience relevant to the device’s technology, intended purpose, and clinical evaluation requirements.

What resources are available within my organisation? Manufacturers with established clinical and regulatory teams may require assistance with specific activities, while others may need support across the clinical evaluation process.

What is my available budget? The manufacturer should consider the proposed cost alongside the services, expertise, and deliverables included in the quotation.

What work is required to meet the applicable EU MDR requirements? The provider should be able to support the clinical evidence assessment and documentation needed to demonstrate the device’s safety, performance, and clinical benefits, including addressing relevant notified body findings where applicable.

What information should manufacturers provide when requesting a quotation?

Device details: Device description, classification, intended purpose, clinical claims, and any variants or configurations covered by the project.

Existing clinical evaluation documentation: The current CER and Clinical Evaluation Plan (CEP), where applicable.

Available clinical evidence: Relevant clinical investigation reports, published literature, and previous literature searches.

Post-market documentation: Relevant PMS and PMCF reports and findings.

Regulatory status: Current certification status, identified clinical evidence gaps, and any relevant notified body findings.

Project requirements: Expected deliverables, completion timeline, and any specific areas requiring additional support.

Questions to ask before hiring a CER writer

What activities and deliverables are included in the quoted price? Confirm whether the quotation covers literature searches, clinical data appraisal, review of existing clinical and post-market evidence, CER drafting, and quality review.

Is CEP development or review included? Establish whether the existing CEP will be reviewed or updated and whether preparing a new CEP would involve an additional fee.

How many revision rounds are included? Clarify the arrangements for reviewing draft reports and incorporating manufacturer feedback.

Is notified body deficiency support included? Confirm whether responses to notified body questions are covered by the original quotation or require a separate agreement.

What information and resources must the manufacturer provide? Establish responsibility for supplying the necessary documentation and access to relevant internal specialists.

How will additional work be handled? Clarify the process for approving changes to the project scope, additional fees, and any resulting changes to the delivery timeline.

Comparison Table: CER Writing Pricing Models

Checklist: Before Accepting a CER Writing Quotation

Scope and deliverables:

• Confirmed which activities are included: CEP development, literature search, clinical data appraisal, state-of-the-art assessment, PMS and PMCF review, benefit-risk assessment, CER drafting, quality review
• Confirmed which device variants, configurations, and indications are covered
• Established whether the quotation covers a new CER or an update to an existing report

Revisions and additional work:

• Clarified how many revision rounds are included in the fixed price
• Established the process for approving additional work and how it will affect cost and timeline
• Confirmed whether notified body deficiency support is included or requires a separate agreement

Provider expertise:

• Confirmed the provider has experience with the specific device technology and clinical evidence requirements
• Assessed whether the provider’s regulatory expertise covers the applicable EU MDR requirements for the device classification
• Verified references or examples of comparable CER writing work where possible

Documentation and responsibilities:

• Established what documentation the manufacturer must provide and when
• Confirmed responsibility for providing access to internal clinical and regulatory specialists where needed
• Agreed how newly available clinical evidence identified during the project will be handled

Commercial terms:

• Confirmed the payment structure and milestone schedule where applicable
• Established the agreed delivery timeline and any conditions that may affect it
• Clarified intellectual property ownership of the completed CER and supporting documentation

Definitions

Clinical Evaluation Report (CER)
The document in which a manufacturer compiles, evaluates, and documents the clinical evidence supporting a medical device’s safety, performance, clinical benefits, and benefit-risk profile. Required under Article 61 and Annex XIV of the EU MDR, the CER must be maintained throughout the device lifecycle.

Clinical Evaluation Plan (CEP)
The document that defines the scope, methodology, and evidence requirements for the clinical evaluation, including the device’s intended purpose, clinical claims, and planned literature search strategy. Required under Annex XIV of the EU MDR.

CER writer
A clinical or regulatory professional who prepares, updates, or reviews Clinical Evaluation Reports. CER writers may work as independent freelancers or as part of a regulatory consultancy. The expertise required depends on the device technology, clinical evidence complexity, and applicable EU MDR requirements.

Fixed-price CER project
A CER writing engagement where an agreed fee covers a defined scope of work and deliverables. Additional activities outside the agreed scope are typically billed separately.

Hourly CER writing rate
A pricing model where the manufacturer pays for the time spent on agreed clinical evaluation activities. Total cost depends on the writer’s hourly rate and the number of hours required.

Retainer agreement
An ongoing support arrangement covering defined clinical evaluation activities across an agreed period, typically used for lifecycle CER maintenance, literature surveillance, and review of new post-market evidence.

State-of-the-art assessment
The review of current clinical practice, available treatment or diagnostic alternatives, relevant clinical guidelines, and accepted safety and performance benchmarks in the relevant clinical field. A required component of clinical evaluation under MEDDEV 2.7/1 Rev 4.

Benefit-risk assessment
The formal evaluation of whether the clinical benefits of a medical device outweigh its risks in the context of the available clinical evidence. Required as part of clinical evaluation under Article 61 of the EU MDR.

Expert Perspective

The most consistent problem in CER writing procurement is manufacturers comparing quotations that do not cover the same scope. A CER writing quotation that includes a systematic literature review, clinical data appraisal, state-of-the-art assessment, benefit-risk evaluation, and quality review is not directly comparable to one that covers drafting alone. The lower quotation is not always the better value when the activities it excludes need to be procured separately or are absent from the final document. Notified Bodies assess the quality of the clinical evaluation, not the price paid for it. A CER that appears complete but lacks genuine critical appraisal of the clinical evidence is one of the most common reasons submissions are challenged during conformity assessment, regardless of cost.

Frequently Asked Questions

How much does a CER writer charge per hour?

Advertised freelance CER writing rates on one specialist platform range from USD 30 to USD 110 per hour. Actual rates vary by provider, device complexity, and project scope. Writers with specialised clinical and EU MDR regulatory expertise relevant to specific device technologies may charge higher rates. These figures are indicative rather than industry-standard rates and reflect publicly advertised pricing in September 2026.

How much does a complete CER cost?

There is no standard price. Fixed-price examples from one regulatory consultancy range from USD 6,100 for Class I devices to USD 12,400 for Class III devices, covering the Clinical Evaluation Plan, CER, systematic literature review, and clinical data analysis. The actual cost for any project depends on the device, available evidence, and agreed scope of work. These figures represent one provider’s published pricing and do not establish standard CER costs across the industry.

How long does it take to prepare a CER?

There is no standard turnaround time. The provider should confirm a realistic timeline after assessing the project scope and available documentation. Factors affecting timeline include device complexity, the volume of clinical evidence to be reviewed, the condition of existing documentation, and the number of revision rounds required.

Is a CER update cheaper than preparing a new CER?

Often, but not always. An update may cost less when the existing CER is well maintained and current clinical evidence is available. However, significant evidence gaps, outdated literature reviews, or inconsistencies with PMS and PMCF findings can increase the work required to the point where the update approaches the cost of a new CER.

Can I hire a CER writer only for the literature review?

Yes. Manufacturers can engage a specialist for literature review alone, provided the agreed scope and deliverables are clearly defined. Targeted literature review support is commonly used for periodic CER updates, surveillance literature searches, and support with specific evidence gaps identified during regulatory review.

What should I look for when choosing a CER writer?

The provider should have clinical and regulatory expertise relevant to the specific device technology, intended purpose, and classification. They should be able to critically appraise clinical evidence rather than simply compile and summarise it. Manufacturers should confirm what activities are included in the quotation, how revisions and additional work are handled, and whether the provider has experience supporting CER submissions through notified body assessment for comparable devices.

What are the most common reasons CERs fail Notified Body review?

The most common reasons include insufficient critical appraisal of clinical evidence, misaligned literature search strategies, inconsistencies between the CER and PMS or PMCF documentation, inadequate state-of-the-art assessment, and an outdated evidence base that does not reflect recent post-market data. For a full breakdown see our article on reasons Clinical Evaluation Reports are rejected.

References

• Regulation (EU) 2017/745 on medical devices (EU MDR) — particularly Article 61 and Annex XIV
• MEDDEV 2.7/1 Revision 4: Clinical Evaluation Guide
• Kolabtree. Clinical Evaluation Report Writing: Freelance Writer Rates. Accessed September 2026
• Celegence. CER EU MDR Pricing. Accessed September 2026
• Pricing information reflects publicly advertised rates and packages available in September 2026 and may change

Related Resources

• CER Writing Services — Expert CER writing and clinical evaluation support for medical device manufacturers
• CER Checklist for EU MDR — A practical framework for pre-submission review of Clinical Evaluation Reports
• Why Clinical Evaluation Reports Are Rejected — Common reasons CERs fail Notified Body review and how to avoid them
• EU MDR Literature Review Services — Structured literature surveillance supporting CER development and maintenance
• Post-Market Surveillance Under EU MDR — Building a proactive PMS system aligned with EU MDR expectations
• PMCF Surveys Solution — Structured PMCF activities supporting ongoing clinical evidence generation
• PRISMA and EU MDR Literature Review — Structured literature review methodology supporting CER development
• EU MDR Consulting Services — Expert regulatory support for clinical evaluation and EU MDR compliance

Call to Action

If you are preparing a new Clinical Evaluation Report, updating an existing CER, or building a more structured approach to clinical evaluation and literature surveillance under EU MDR, Citemeds can help. Get in touch to discuss your requirements.